Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01520987 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects
A Phase 1 study, sponsored by Bial - Portela C S.A..
- Completed
- Registry status
- Phase 1
- Development phase
- 105
- Enrollment target
NCT01520987: Completed Phase 1 study, sponsored by Bial - Portela C S.A..
NCT01520987 is a Phase 1 study that has completed, run by Bial - Portela C S.A.. The registered enrollment target is 105 participants, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01520987, a Phase 1 study, has completed, sponsored by Bial - Portela C S.A..
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 105 participants
- Enrollment target
Study Summary
To assess the pharmacokinetics of BIA 9-1067 in healthy Japanese subjects
Primary Outcome
Cmax - maximum observed plasma concentration following single (Day 1) oral administrations of 5, 25 and 50 mg OPC in healthy Japanese and matched healthy Caucasian subjects Blood samples collected for PK analysis at the following timepoints: on Day 1 at pre-dose (within 1 hour before dose administration) and 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 16, and 24 hours post-dose.
Interventions
- DRUG Placebo
- DRUG BIA 9-1067
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 105 participants |
| Start Date | 2011-05 |
| Est. Completion | 2012-11 |
| Phase | Phase 1 |
What the finished NCT01520987 record still lists
NCT01520987 is an interventional study that assigns participants to a tested intervention. The registered 105 participants enrollment target is mid-sized for trials with a published cap, above the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (75% higher).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01520987 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01520987 about?
NCT01520987 is a clinical study titled "Pharmacokinetics of BIA 9-1067 in Healthy Japanese and Caucasian Subjects". To assess the pharmacokinetics of BIA 9-1067 in healthy Japanese subjects
What is the current status of trial NCT01520987?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 105 participants. The study started on 2011-05. Estimated completion is 2012-11.
What interventions are being tested in trial NCT01520987?
The interventions under investigation include: Placebo (DRUG), BIA 9-1067 (DRUG).
Who is sponsoring clinical trial NCT01520987?
This trial is sponsored by Bial - Portela C S.A., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01520987's enrollment target sits among peer trials
105 533rd of 2000 higher than 1,465 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03372317 · 105 participants
Tau PET in Imaging and Cognition: Healthy Adults From 55-90
- NCT04253964 · 105 participants · Phase 2
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
- NCT04742452 · 105 participants · NA
Comparison of Partial Rotator Cuff Repair vs. Superior Capsular Reconstruction for Irreparable Rotator Cuff Tears
- NCT04875429 · 105 participants · NA
Zenith® Fenestrated+ Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia